VRTX earnings call for the period ending September 30, 2024.…
…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten der Oppenheimer senken das Kursziel für die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…
Its latest report of clinical data suggests it has a winner on its hands.…
Its latest report of clinical data suggests it has a winner on its hands.…
…
…
Charlotte (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BofA Securities:
Rating und Kursziel
BofA-Analyst Geoff Meacham hat das Kursziel für Vertex Pharmaceuticals Inc. (ISIN:…
Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets:
Rating und Kursziel
RBC Capital Markets hat das Kursziel für die Aktie von…
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Morgan Stanley:
1. Anpassung des Kursziels und Bewertung
- Morgan Stanley hat das Kursziel für…
Vertex Pharmaceuticals isnt an ordinary biotech stock.…
Vertex Pharmaceuticals isnt an ordinary biotech stock.…
Vertex Pharmaceuticals isnt an ordinary biotech stock.…
…
…
Vertex should have a future full of bright tomorrows.…
Vertex should have a future full of bright tomorrows.…
Vertex Pharmaceuticals has a lot going for it.…
…
Shares of the rare disease drugmaker are already up more than 40% over the past year.…
Shares of the rare disease drugmaker are already up more than 40% over the past year.…
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Oppenheimer:
Oppenheimer hebt in einer aktuellen Aktienanalyse das Kursziel für die Aktie von Vertex…
Charlotte, NC (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Truist:
Joon Lee, Analyst von Truist, stuft in einer aktuellen Aktienanalyse die Aktie von…
London (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Barclays:
Barclays stuft in einer aktuellen Aktienanalyse die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…
New York (www.aktiencheck.de) - Rating-Update:
Andrew Fein, Analyst von H.C. Wainwright & Co, empfiehlt die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…
VRTX earnings call for the period ending June 30, 2024.…
Vancouver (www.aktiencheck.de) - Rating-Update:
Die Analysten von Canaccord Genuity bewerten die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…
San Francisco (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Citizens JMP Securities:
Die Analysten von Citizens JMP Securities heben in einer aktuellen Aktienanalyse…
As a shareholder, I am nowhere close to panic mode.…
Vertex shares have soared by triple-digit percentages over the past three years.…
Vertex shares have soared by triple-digit percentages over the past three years.…
Milwaukee (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Robert W. Baird:
Die Analysten von Robert W. Baird nehmen die Coverage der Aktie von…
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von H.C. Wainwright & Co.:
Die Analysten von H.C. Wainwright & Co. stufen die Aktie…
Vertex Pharmaceuticals EVP and CMO sells $1.1M in stock…
Vertex Pharmaceuticals likely has a breakthrough medicine on its hands.…
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Redburn Atlantic nehmen die Coverage der Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…
BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to…
San Francisco (www.aktiencheck.de) - Rating-Update:
Die Analysten von Wells Fargo Advisors stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Argus Research:
Jasper Hellweg, Analyst von Argus Research, erhöht in einer aktuellen Aktienanalyse sein…
…
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics - Global Strategic Business Report" report has…
Toronto (www.aktiencheck.de) - Rating-Update:
Die Analysten vom Investmenthaus RBC Capital Markets bestätigen das "sector-perform"-Rating für die Aktie von Vertex Pharmaceuticals Inc.…
Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BMO Capital Markets:
Die Analysten von BMO Capital Markets stufen die Aktie von Vertex Pharmaceuticals…
Shares of the growing biotech company have doubled in three years.…
Shares of the growing biotech company have doubled in three years.…
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.…
Axelerist, an ADDvise Group company, has received an order from Vertex Pharmaceuticals, a global biotechnology company, for the sale and…
Vertex Pharmaceuticals executive sells shares worth over $13k…
Vertex Pharmaceuticals (NDAQ: VRTX) path to becoming a top 20 pharma company with over a $100 billion market cap has…
The biotechs shares dropped following its latest quarterly update, but that shouldnt matter to long-term investors.…